Damon Runyon Cancer Study Foundation grants fellowship awards to 21 …
Elucidating how cancer cells differ from standard cells will ultimately contribute to the development of novel therapeutic possibilities for the treatment of cancer. Angela N. Brooks, PhD, with her sponsor Matthew L. Meyerson, MD, PhD, at Dana-Farber Cancer …
Read more on Phys.Org (press release)
Greater Finish Of Life Top quality Of Life For Cancer Patients
In many situations, when cancer patients are left with no further choices to treat their illness, the focus shifts from prolonging life to promoting the quality of life (QOL) at the end of life (EOL). Now, researchers have identified elements that influence …
Read more on Medical News Right now
PHARMAC funds new targeted lung cancer drug
PHARMAC funds new targeted lung cancer drug. Funded therapy options for New Zealand's most typical form of cancer will take a step forward in August when PHARMAC starts funding gefitinib (Iressa), a targeted treatment for lung cancer. PHARMAC …
Read more on Scoop.co.nz (press release)
Leave a Reply
You must be logged in to post a comment.